Bain Capital Life Sciences Investors, LLC Q3 2022 Filing

Filed November 14, 2022

Portfolio Value

$837.8B

Holdings

33

Report Date

Q3 2022

Filing Type

13F-HR

All Holdings (33 positions)

#StockSharesValue% PortfolioType
1
SWTXSPRINGWORKS THERAPEUTICS INC
4,831,307$137.8B16.45%
2
NUVLNUVALENT INC
3,428,014$66.6B7.95%
3
MERSANA THERAPEUTICS INC
8,663,673$58.6B6.99%
4
ARQTARCUTIS BIOTHERAPEUTICS INC
3,000,000$57.3B6.84%
5
DVAXDYNAVAX TECHNOLOGIES CORP
5,415,000$56.5B6.75%
6
EQRX INC
10,003,573$49.5B5.91%
7
CRNXCRINETICS PHARMACEUTICALS IN
2,305,558$45.3B5.41%
8
THRDTHIRD HARMONIC BIO INC
2,280,082$43.3B5.16%
9
AMLXAMYLYX PHARMACEUTICALS INC
1,023,214$28.8B3.44%
10
RPIDRAPID MICRO BIOSYSTEMS INC
8,434,560$27.2B3.25%
11
CARAEURCARA THERAPEUTICS INC
2,647,473$24.8B2.96%
12
PHVSPHARVARIS N V
3,180,601$24.4B2.91%
13
NRIXNURIX THERAPEUTICS INC
1,822,883$23.8B2.84%
14
ANNXANNEXON INC
3,601,926$22.3B2.66%
15
TSVT*2SEVENTY BIO INC
1,408,901$20.5B2.45%
16
PTGXPROTAGONIST THERAPEUTICS INC
2,260,572$19.1B2.27%
17
YB4PSAVARA INC
11,622,598$18.0B2.15%
18
CCCCC4 THERAPEUTICS INC
1,642,210$14.4B1.72%
19
AVIRATEA PHARMACEUTICALS INC
2,485,638$14.1B1.69%
20
ASNSUSDX4 PHARMACEUTICALS INC
6,389,436$10.9B1.30%
21
ACADACADIA PHARMACEUTICALS INC
610,523$10.0B1.19%
22
MRNS*MARINUS PHARMACEUTICALS INC
1,431,058$9.5B1.14%
23
XLOXILIO THERAPEUTICS INC
2,805,413$8.2B0.97%
24
SYRSSYROS PHARMACEUTICALS INC
1,082,404$7.0B0.83%
25
TNGXTANGO THERAPEUTICS INC
1,921,790$7.0B0.83%
26
IVVDINVIVYD INC
1,937,207$6.1B0.72%
27
ARYA SCIENCES ACQUISITN CORP
500,000$4.9B0.59%
28
BCLS ACQUISITION CORP
487,500$4.9B0.58%
29
NAUTNAUTILUS BIOTECHNOLOGY INC
2,000,000$4.2B0.51%
30
SLDBSOLID BIOSCIENCES INC
7,929,918$3.7B0.44%
31
APTINYX INC
8,891,758$3.3B0.39%
32
FRAZIER LIFESCIENCES ACQU CO
300,000$3.0B0.36%
33
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
5,347,689$2.8B0.34%